Literature DB >> 26505186

[Multidrug-Resistant Organisms (MDRO) in Rehabilitation Clinics in the Rhine-Main-District, Germany, 2014: Prevalence and Risk Factors].

U Heudorf1, D Färber1, D Mischler1, M Schade1, C Zinn2, C Cuny3, D Nillius4, M Herrmann4.   

Abstract

BACKGROUND: While a limited number of studies have investigated the prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in medical rehabilitation institutions, almost no data on the colonization of rehabilitation patients with multiresistant gram-negative rods is available. Here we report on a large multicenter study on the prevalence of MRSA and multiresistant pathogens in rehabilitation institutions in the Rhine-Main area in 2014.
MATERIALS AND METHODS: Altogether, 21 rehabilitation hospitals participated. For all patients, age, gender, previous history of hospitalizations, surgery, previous colonization with multidrug-resistant organisms, use of a medical device, current antimicrobial therapy, and the current infection status were ascertained. On voluntary basis, nare and throat swabs were taken for analysis of MRSA and rectal swabs were tested for extended spectrum betalactamase-producing gram-negative bacteria (ESBL).
RESULTS: 50% of 2 440 patients had a history of hospitalization within the previous 6 months while 39% had undergone surgery during the past 30 days. Approximately a quarter of the patients had been transferred to a rehabilitation hospital directly from an acute care hospital, had been under antimicrobial therapy with the past three months, or had travelled to a foreign country within the previous year. Risk factors such as lesions of the intact skin or presence of medical devices were rarely reported (< 5%) within the exception of patients undergoing geriatric or neurologic acute care rehabilitation. 0.7% (15/2155) of the patients were colonized with MRSA, while 7.7% (110/1434) showed a positive result for ESBL. The highest prevalence rates for multiresistant organisms were encountered among patients with neurologic rehabilitation (MRSA, 1.3%, and ESBL, 10.2%) or with geriatric rehabilitation (MRSA, 9.4%, and ESBL, 22.7%).
CONCLUSION: In the rehabilitation patient population, the prevalence rates of MRSA and ESBL were found to be in the range of rates encountered in the general population (reported rates for MRSA, 0.5%, and ESBL, 6.3%). The known risk factors for MRSA such as skin lesions, medical devices and previous history for MRSA were also confirmed among this patient population. Direct transfer from an acute care hospital, antimicrobial treatment during the past 3 months, and wounds proved significant risk factors for ESBL colonization. Patients of neurologic rehabilitation and geriatric patients showed the highest rates of risk factors and the highest prevalence rates of multidrug-resistant organisms. It appears to be of importance for rehabilitation hospitals to be geared to the needs of patients with multidrug-resistant organisms, and prevent the transmission of these pathogens by appropriate hygiene measures. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2015        PMID: 26505186     DOI: 10.1055/s-0035-1559642

Source DB:  PubMed          Journal:  Rehabilitation (Stuttg)        ISSN: 0034-3536            Impact factor:   1.113


  5 in total

1.  A Study of 24 Patients with Colistin-Resistant Gram-negative Isolates in a Tertiary Care Hospital in South India.

Authors:  Rajalakshmi Arjun; Ram Gopalakrishnan; P Senthur Nambi; D Suresh Kumar; R Madhumitha; V Ramasubramanian
Journal:  Indian J Crit Care Med       Date:  2017-05

2.  Understanding institutional stakeholders' perspectives on multidrug-resistant bacterial organism at the end of life: a qualitative study.

Authors:  Maria Heckel; Franziska A Herbst; Thomas Adelhardt; Johanna M Tiedtke; Alexander Sturm; Stephanie Stiel; Christoph Ostgathe
Journal:  Clin Interv Aging       Date:  2017-10-03       Impact factor: 4.458

3.  Patients with Rheumatic Diseases do not have an Increased Risk of MRSA Carrier Status.

Authors:  Judith Krämer; Konstantinos Triantafyllias; Wolfgang Kohnen; Martin Leber; Ute Dederichs-Masius; Andrea Zucker; Jürgen Körber; Andreas Schwarting
Journal:  Rheumatol Ther       Date:  2018-06-02

4.  ESBL colonization and acquisition in a hospital population: The molecular epidemiology and transmission of resistance genes.

Authors:  Stefan Hagel; Oliwia Makarewicz; Anita Hartung; Daniel Weiß; Claudia Stein; Christian Brandt; Ulrike Schumacher; Ralf Ehricht; Vladimir Patchev; Mathias W Pletz
Journal:  PLoS One       Date:  2019-01-14       Impact factor: 3.240

5.  Long-term complications and implant survival rates after cranioplastic surgery: a single-center study of 392 patients.

Authors:  Henrik Giese; Jennifer Meyer; Andreas Unterberg; Christopher Beynon
Journal:  Neurosurg Rev       Date:  2020-08-26       Impact factor: 3.042

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.